Business Segments — Gain on deconsolidation
Roivant Sciences Business Segments — Gain on deconsolidation remained flat by 0.0% to $2.76M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 254.8%, from $777.00K to $2.76M. Over 2 years (FY 2023 to FY 2025), Business Segments — Gain on deconsolidation shows a downward trend with a -42.0% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates successful value creation and monetization of incubated ventures, while a decrease suggests fewer divestitures or spin-offs.
Detailed definition
This represents the accounting gain recognized when the company loses control of a subsidiary, typically through a spin-...
Peer comparison
Common for companies with venture-like business models that incubate and spin off independent entities.
roiv_segment_reportable_segment_gain_on_deconsolidationHistorical Data
| FY'23 | FY'24 | FY'25 | |
|---|---|---|---|
| Value | $32.77M | $3.11M | $11.03M |
| YoY Change | — | -90.5% | +254.8% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Roivant Sciences's business segments — gain on deconsolidation?
- Roivant Sciences (ROIV) reported business segments — gain on deconsolidation of $2.76M in Q1 2026.
- How has Roivant Sciences's business segments — gain on deconsolidation changed year-over-year?
- Roivant Sciences's business segments — gain on deconsolidation increased by 254.8% year-over-year, from $777.00K to $2.76M.
- What is the long-term trend for Roivant Sciences's business segments — gain on deconsolidation?
- Over 2 years (2023 to 2025), Roivant Sciences's business segments — gain on deconsolidation has grown at a -42.0% compound annual growth rate (CAGR), from $32.77M to $11.03M.
- What does business segments — gain on deconsolidation mean?
- The accounting profit recorded when a subsidiary is no longer controlled by the parent company.